Nico Gagelmann
@nicogagelmann.bsky.social
Hematologist. Academic. Train. Think. Let's create and integral and loving actuality.
Pinned
Nico Gagelmann
@nicogagelmann.bsky.social
· Oct 12
Finally in Boston!
Honored to join @danafarber.bsky.social, eager to learn and contribute in this terrific community @coleman-lindsley.bsky.social.
A place of science, purpose and hope.
Honored to join @danafarber.bsky.social, eager to learn and contribute in this terrific community @coleman-lindsley.bsky.social.
A place of science, purpose and hope.
Reposted by Nico Gagelmann
@nicogagelmann.bsky.social shares findings that longer telomeres in donors ≥35 are associated with reduced graft failure and lower non-relapse mortality following allogeneic HCT. #ASH25
December 6, 2025 at 9:02 PM
@nicogagelmann.bsky.social shares findings that longer telomeres in donors ≥35 are associated with reduced graft failure and lower non-relapse mortality following allogeneic HCT. #ASH25
Reposted by Nico Gagelmann
Don't get left out at sea! Prepare now for ASH-a-Palooza at #ASH25🐬
◽Sign up early for Blood Buddy speed mentoring: https://ow.ly/Cafw50XA6Gt
◽Arrive by 11:45 a.m. for the Global Hematology Trainee Networking Lunch
◽Join the AAP treasure hunt ( in the #ASH25 app)
#ASHTrainee ASH Education
◽Sign up early for Blood Buddy speed mentoring: https://ow.ly/Cafw50XA6Gt
◽Arrive by 11:45 a.m. for the Global Hematology Trainee Networking Lunch
◽Join the AAP treasure hunt ( in the #ASH25 app)
#ASHTrainee ASH Education
December 1, 2025 at 5:10 PM
Don't get left out at sea! Prepare now for ASH-a-Palooza at #ASH25🐬
◽Sign up early for Blood Buddy speed mentoring: https://ow.ly/Cafw50XA6Gt
◽Arrive by 11:45 a.m. for the Global Hematology Trainee Networking Lunch
◽Join the AAP treasure hunt ( in the #ASH25 app)
#ASHTrainee ASH Education
◽Sign up early for Blood Buddy speed mentoring: https://ow.ly/Cafw50XA6Gt
◽Arrive by 11:45 a.m. for the Global Hematology Trainee Networking Lunch
◽Join the AAP treasure hunt ( in the #ASH25 app)
#ASHTrainee ASH Education
Reposted by Nico Gagelmann
The #ASH25 virtual platform is now live! Log in now using the ASH username and password you used to register for the annual meeting: https://ow.ly/MmlR50XBiMT
🌟Your bonus and preview content await. Plus, explore networking, exhibits, and more on the virtual platform! #HemeSky #MedSky
🌟Your bonus and preview content await. Plus, explore networking, exhibits, and more on the virtual platform! #HemeSky #MedSky
December 3, 2025 at 3:30 PM
The #ASH25 virtual platform is now live! Log in now using the ASH username and password you used to register for the annual meeting: https://ow.ly/MmlR50XBiMT
🌟Your bonus and preview content await. Plus, explore networking, exhibits, and more on the virtual platform! #HemeSky #MedSky
🌟Your bonus and preview content await. Plus, explore networking, exhibits, and more on the virtual platform! #HemeSky #MedSky
Reposted by Nico Gagelmann
Your go-to social media guide for #ASH25 is here. Find tips on following updates, taking part in conversations, using the official hashtags, and entering fun challenges with #ASHNewsDaily.
Read now: https://ow.ly/tEgJ50XxAP6
#HemeSky #ASHaiku #ASHKudos #ASHRunWalk #ASHScavengerHunt
Read now: https://ow.ly/tEgJ50XxAP6
#HemeSky #ASHaiku #ASHKudos #ASHRunWalk #ASHScavengerHunt
November 25, 2025 at 5:15 PM
Your go-to social media guide for #ASH25 is here. Find tips on following updates, taking part in conversations, using the official hashtags, and entering fun challenges with #ASHNewsDaily.
Read now: https://ow.ly/tEgJ50XxAP6
#HemeSky #ASHaiku #ASHKudos #ASHRunWalk #ASHScavengerHunt
Read now: https://ow.ly/tEgJ50XxAP6
#HemeSky #ASHaiku #ASHKudos #ASHRunWalk #ASHScavengerHunt
Reposted by Nico Gagelmann
The ASH annual meeting is the premier venue for #hematology collaborations across borders 🌏
#ASHThrowback to a meeting with ASH and the Mediterranean Partner Societies at #ASH24. Belinda Avalos, MD #ASH25
International community, share your throwbacks from past ASH meetings! #HemeSky
#ASHThrowback to a meeting with ASH and the Mediterranean Partner Societies at #ASH24. Belinda Avalos, MD #ASH25
International community, share your throwbacks from past ASH meetings! #HemeSky
November 27, 2025 at 7:05 PM
The ASH annual meeting is the premier venue for #hematology collaborations across borders 🌏
#ASHThrowback to a meeting with ASH and the Mediterranean Partner Societies at #ASH24. Belinda Avalos, MD #ASH25
International community, share your throwbacks from past ASH meetings! #HemeSky
#ASHThrowback to a meeting with ASH and the Mediterranean Partner Societies at #ASH24. Belinda Avalos, MD #ASH25
International community, share your throwbacks from past ASH meetings! #HemeSky
Finally in Boston!
Honored to join @danafarber.bsky.social, eager to learn and contribute in this terrific community @coleman-lindsley.bsky.social.
A place of science, purpose and hope.
Honored to join @danafarber.bsky.social, eager to learn and contribute in this terrific community @coleman-lindsley.bsky.social.
A place of science, purpose and hope.
October 12, 2025 at 11:45 AM
Finally in Boston!
Honored to join @danafarber.bsky.social, eager to learn and contribute in this terrific community @coleman-lindsley.bsky.social.
A place of science, purpose and hope.
Honored to join @danafarber.bsky.social, eager to learn and contribute in this terrific community @coleman-lindsley.bsky.social.
A place of science, purpose and hope.
Thank you all who made COSTEM 2025 THE event for transplant & cellular therapies❗️
Faculty who fight REAL debates
Audience that ask REAL questions
Unity amid controversy🙏
See you 1-3 October 2026 in Berlin again!
Faculty who fight REAL debates
Audience that ask REAL questions
Unity amid controversy🙏
See you 1-3 October 2026 in Berlin again!
September 29, 2025 at 6:16 AM
Thank you all who made COSTEM 2025 THE event for transplant & cellular therapies❗️
Faculty who fight REAL debates
Audience that ask REAL questions
Unity amid controversy🙏
See you 1-3 October 2026 in Berlin again!
Faculty who fight REAL debates
Audience that ask REAL questions
Unity amid controversy🙏
See you 1-3 October 2026 in Berlin again!
Last Call for Early Bird Registration
Join us at the 10th COSTEM Congress!
🗓️ September 25–28, 2025
📍 Berlin, Germany
Don't miss your chance to save – Early Bird registration closes July 31st!
costem.cme-congresses.com/registration/
Join us at the 10th COSTEM Congress!
🗓️ September 25–28, 2025
📍 Berlin, Germany
Don't miss your chance to save – Early Bird registration closes July 31st!
costem.cme-congresses.com/registration/
Registration - COSTEM Congress 2025
Registration for COSTEM 2025
costem.cme-congresses.com
July 28, 2025 at 8:20 AM
Last Call for Early Bird Registration
Join us at the 10th COSTEM Congress!
🗓️ September 25–28, 2025
📍 Berlin, Germany
Don't miss your chance to save – Early Bird registration closes July 31st!
costem.cme-congresses.com/registration/
Join us at the 10th COSTEM Congress!
🗓️ September 25–28, 2025
📍 Berlin, Germany
Don't miss your chance to save – Early Bird registration closes July 31st!
costem.cme-congresses.com/registration/
Reposted by Nico Gagelmann
🎥 Check out our recent interview from #CART25 with @nicogagelmann.bsky.social, in which he highlights the need to address inequality & inequity in access to #CARTCell therapy across Europe:
👉 buff.ly/4gBhWeD
#ImmunoOnc #HemOnc #Hematology #MedSky #BloodSky #HemeSky
👉 buff.ly/4gBhWeD
#ImmunoOnc #HemOnc #Hematology #MedSky #BloodSky #HemeSky
February 18, 2025 at 3:54 PM
🎥 Check out our recent interview from #CART25 with @nicogagelmann.bsky.social, in which he highlights the need to address inequality & inequity in access to #CARTCell therapy across Europe:
👉 buff.ly/4gBhWeD
#ImmunoOnc #HemOnc #Hematology #MedSky #BloodSky #HemeSky
👉 buff.ly/4gBhWeD
#ImmunoOnc #HemOnc #Hematology #MedSky #BloodSky #HemeSky
Reposted by Nico Gagelmann
Out now in Blood Advances 🙌🏽
Our work from Princess Margaret Cancer Centre evaluating the role of PTCy in matched sibling donor allogeneic transplantation!
Also read this excellent commentary by my good friend @nicogagelmann.bsky.social 👇🏽
ashpublications.org/bloodadvance...
Our work from Princess Margaret Cancer Centre evaluating the role of PTCy in matched sibling donor allogeneic transplantation!
Also read this excellent commentary by my good friend @nicogagelmann.bsky.social 👇🏽
ashpublications.org/bloodadvance...
February 12, 2025 at 4:41 AM
Out now in Blood Advances 🙌🏽
Our work from Princess Margaret Cancer Centre evaluating the role of PTCy in matched sibling donor allogeneic transplantation!
Also read this excellent commentary by my good friend @nicogagelmann.bsky.social 👇🏽
ashpublications.org/bloodadvance...
Our work from Princess Margaret Cancer Centre evaluating the role of PTCy in matched sibling donor allogeneic transplantation!
Also read this excellent commentary by my good friend @nicogagelmann.bsky.social 👇🏽
ashpublications.org/bloodadvance...
Let's learn hematology in 2025🩸
Day 27: hemophilia characteristics
Day 27: hemophilia characteristics
January 27, 2025 at 1:40 PM
Let's learn hematology in 2025🩸
Day 27: hemophilia characteristics
Day 27: hemophilia characteristics
🎉Finally published🎉
Cilta-cel vs ide-cel for relapsed or refractory multiple myeloma
@hemasphere-journal.bsky.social
onlinelibrary.wiley.com/doi/full/10....
Cilta-cel vs ide-cel for relapsed or refractory multiple myeloma
@hemasphere-journal.bsky.social
onlinelibrary.wiley.com/doi/full/10....
Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study
Idecabtagene vicleucel (ide-cel) and ciltacabtagene autoleucel (cilta-cel) have revolutionized the treatment of relapsed/refractory multiple myeloma (RRMM), but direct comparisons are lacking. Levera...
onlinelibrary.wiley.com
January 19, 2025 at 6:57 PM
🎉Finally published🎉
Cilta-cel vs ide-cel for relapsed or refractory multiple myeloma
@hemasphere-journal.bsky.social
onlinelibrary.wiley.com/doi/full/10....
Cilta-cel vs ide-cel for relapsed or refractory multiple myeloma
@hemasphere-journal.bsky.social
onlinelibrary.wiley.com/doi/full/10....
Reposted by Nico Gagelmann
🎉Finally published🎉
Clearance of driver mutations after transplantation for myelofibrosis
@nejm.org
www.nejm.org/doi/full/10....
Clearance of driver mutations after transplantation for myelofibrosis
@nejm.org
www.nejm.org/doi/full/10....
Clearance of Driver Mutations after Transplantation for Myelofibrosis | NEJM
Allogeneic hematopoietic stem-cell transplantation is the only curative treatment
for myelofibrosis. Driver mutations are the pathophysiological hallmark of the disease,
but the role of mutation cl...
www.nejm.org
January 9, 2025 at 11:05 AM
🎉Finally published🎉
Clearance of driver mutations after transplantation for myelofibrosis
@nejm.org
www.nejm.org/doi/full/10....
Clearance of driver mutations after transplantation for myelofibrosis
@nejm.org
www.nejm.org/doi/full/10....
Reposted by Nico Gagelmann
In a single-group, single-center study, clearance of driver mutations 30 days after bone marrow transplantation predicted long-term disease-free survival in patients with myelofibrosis. Read the full study results: nej.md/4fQNdKn
#MedSky
#MedSky
Clearance of Driver Mutations after Transplantation for Myelofibrosis | NEJM
Allogeneic hematopoietic stem-cell transplantation is the only curative treatment
for myelofibrosis. Driver mutations are the pathophysiological hallmark of the disease,
but the role of mutation cl...
nej.md
January 10, 2025 at 2:12 PM
In a single-group, single-center study, clearance of driver mutations 30 days after bone marrow transplantation predicted long-term disease-free survival in patients with myelofibrosis. Read the full study results: nej.md/4fQNdKn
#MedSky
#MedSky
Reposted by Nico Gagelmann
Reposted by Nico Gagelmann
Reposted by Nico Gagelmann
Talquetamab plus Teclistamab in Multiple Myeloma (RedirecTT-1 study) nej.md/4iZNYTY
Driver Mutations in Myelofibrosis (single-group, single-center study) nej.md/4fQNdKn
Driver Mutations in Myelofibrosis (single-group, single-center study) nej.md/4fQNdKn
January 9, 2025 at 2:14 PM
Talquetamab plus Teclistamab in Multiple Myeloma (RedirecTT-1 study) nej.md/4iZNYTY
Driver Mutations in Myelofibrosis (single-group, single-center study) nej.md/4fQNdKn
Driver Mutations in Myelofibrosis (single-group, single-center study) nej.md/4fQNdKn
Reposted by Nico Gagelmann
a blockbuster paper by @nicogagelmann.bsky.social et al in @nejm.org on the impact of driver mutation clearance in patients with MF that underwent allo-HCT!
www.nejm.org/doi/full/10....
www.nejm.org/doi/full/10....
January 9, 2025 at 1:06 AM
a blockbuster paper by @nicogagelmann.bsky.social et al in @nejm.org on the impact of driver mutation clearance in patients with MF that underwent allo-HCT!
www.nejm.org/doi/full/10....
www.nejm.org/doi/full/10....
🎉Finally published🎉
Clearance of driver mutations after transplantation for myelofibrosis
@nejm.org
www.nejm.org/doi/full/10....
Clearance of driver mutations after transplantation for myelofibrosis
@nejm.org
www.nejm.org/doi/full/10....
Clearance of Driver Mutations after Transplantation for Myelofibrosis | NEJM
Allogeneic hematopoietic stem-cell transplantation is the only curative treatment
for myelofibrosis. Driver mutations are the pathophysiological hallmark of the disease,
but the role of mutation cl...
www.nejm.org
January 9, 2025 at 11:05 AM
🎉Finally published🎉
Clearance of driver mutations after transplantation for myelofibrosis
@nejm.org
www.nejm.org/doi/full/10....
Clearance of driver mutations after transplantation for myelofibrosis
@nejm.org
www.nejm.org/doi/full/10....
Reposted by Nico Gagelmann
December 11, 2024 at 6:33 PM
Reposted by Nico Gagelmann
December 10, 2024 at 8:43 PM
What a wonderful #ASH24
Honored to receive @ash-hematology.bsky.social Abstract Achievement Award, meet friends, celebrate colleagues' achievements, enjoy terrific science and San Diego.
Until next year 🙏🩸❤️
Honored to receive @ash-hematology.bsky.social Abstract Achievement Award, meet friends, celebrate colleagues' achievements, enjoy terrific science and San Diego.
Until next year 🙏🩸❤️
December 10, 2024 at 6:40 PM
What a wonderful #ASH24
Honored to receive @ash-hematology.bsky.social Abstract Achievement Award, meet friends, celebrate colleagues' achievements, enjoy terrific science and San Diego.
Until next year 🙏🩸❤️
Honored to receive @ash-hematology.bsky.social Abstract Achievement Award, meet friends, celebrate colleagues' achievements, enjoy terrific science and San Diego.
Until next year 🙏🩸❤️
Reposted by Nico Gagelmann
Tomorrow @nicogagelmann.bsky.social will take over our Twitter account, bringing you live updates & expert takes straight from #ASH24 🗞️🩸📱
Give us a follow over there so you don't miss the action 👉 x.com/VJHemOnc 👀
Give us a follow over there so you don't miss the action 👉 x.com/VJHemOnc 👀
December 7, 2024 at 5:45 PM
Tomorrow @nicogagelmann.bsky.social will take over our Twitter account, bringing you live updates & expert takes straight from #ASH24 🗞️🩸📱
Give us a follow over there so you don't miss the action 👉 x.com/VJHemOnc 👀
Give us a follow over there so you don't miss the action 👉 x.com/VJHemOnc 👀
Reposted by Nico Gagelmann
Now @nicogagelmann.bsky.social on molecular genetics and JAKi impact on allo-HCT in MF
-1800 rux treated pts
-early allo in high-risk PMF and SMF seems to be best timing
-early allo in TP53 may offer survival benefit
-1800 rux treated pts
-early allo in high-risk PMF and SMF seems to be best timing
-early allo in TP53 may offer survival benefit
December 7, 2024 at 11:03 PM
Now @nicogagelmann.bsky.social on molecular genetics and JAKi impact on allo-HCT in MF
-1800 rux treated pts
-early allo in high-risk PMF and SMF seems to be best timing
-early allo in TP53 may offer survival benefit
-1800 rux treated pts
-early allo in high-risk PMF and SMF seems to be best timing
-early allo in TP53 may offer survival benefit